• Publications
  • Influence
Restless legs syndrome prevalence and impact: REST general population study.
BACKGROUND Restless legs syndrome (RLS), a common sensorimotor disorder, has a wide range of severity from merely annoying to affecting sleep and quality of life severely enough to warrant medicalExpand
Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study.
OBJECTIVES To assess the frequency, impact, and medical response to the restless legs syndrome (RLS) in a large multi-national primary care population. METHOD Questionnaire surveys of matchedExpand
Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment.
RATIONALE Obstructive sleep apnea (OSA) is commonly associated with neurocognitive impairments that have not been consistently related to specific brain structure abnormalities. Knowledge of theExpand
Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP)
The aims of this study were to assess cognitive function in obstructive sleep apnea (OSA) patients and to evaluate the effect of short- and long-term treatment with continuous positive airwayExpand
The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force
The definition and scoring criteria for periodic leg movements (PLM) during sleep have not changed since 1990 [1] and 1993 [2] and are substantially based on the work carried out by Coleman et al. inExpand
Restless Legs Syndrome: Prevalence and Impact in Children and Adolescents—The Peds REST Study
OBJECTIVES. Restless legs syndrome, a common neurologic sleep disorder, occurs in 5% to 10% of adults in the United States and Western Europe. Although ∼25% of adults with restless legs syndromeExpand
Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.
OBJECTIVE To assess the efficacy, safety, and tolerability of ropinirole in the treatment of patients with restless legs syndrome. METHODS A 12 week, prospective, double blind, randomisedExpand
Sleep and quantitative EEG in neurodegenerative disorders.
This paper reviews current knowledge on sleep problems, sleep architecture changes and quantitative EEG alteration brought on by various neurodegenerative diseases, such as Alzheimer's disease (AD),Expand
Epidemiology of obstructive sleep apnea syndrome.
The association of obstructive sleep apnea (OSA) syndrome with obesity, hypertension and cardiovascular disease has highlighted the broad public health importance of this condition. OSA affects atExpand
Burden of restless legs syndrome on health-related quality of life
ObjectiveTo quantify the total and unique burden of Restless Legs Syndrome (RLS) on patient-reported health-related quality of life (HRQoL).MethodsThe disease burden that RLS places on HRQoL wasExpand